Vir Biotechnology, Inc. VIR Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $283.04M+17.4% | $241.07M+34.5% | $179.26M-41.5% | $306.28M-16.8% | $368M+15.5% | ||
| $196.28M-14.2% | $228.75M-30.2% | $327.75M-15.5% | $387.65M-25.1% | $517.37M-23.7% | ||
| $8.9M+363% | $1.92M-79.1% | $9.2M-90.3% | $95.2M+0.8% | $94.4M+5.6% | ||
| $168.33M+1.4% | $165.96M-1.5% | $168.54M-3.5% | $174.67M+0.4% | $173.93M-4.2% | ||
| $522.99M+1.7% | $514.08M-5.8% | $545.68M-25.8% | $735.71M-21.1% | $932.21M-10.6% | ||
| $53.16M-4.4% | $55.62M-4.4% | $58.2M-4.3% | $60.8M-1.4% | $61.68M-2.4% | ||
| $49.9M+5.8% | $47.16M+6.0% | $44.49M+7.0% | $41.56M+6.9% | $38.87M+5.7% | ||
| $60.76M-2.2% | $62.1M-2.3% | $63.56M-2.0% | $64.85M+10.7% | $58.56M-1.9% | ||
| $16.94M0.0% | $16.94M0.0% | $16.94M0.0% | $16.94M0.0% | $16.94M0.0% | ||
| $7.78M-0.9% | $7.85M-0.9% | $7.92M-0.9% | $8M-0.9% | $8.07M-0.6% | ||
| $24.04M-2.7% | $24.7M+54.6% | $15.98M+21.2% | $13.19M+125% | $5.86M-51.4% | ||
| $332.97M+5.8% | $314.58M+3.4% | $304.21M+6.3% | $286.1M+31.2% | $218.14M+14.8% | ||
| $5.9M-2.9% | $6.08M-30.1% | $8.7M+19.2% | $7.3M-31.8% | $10.7M— | ||
| $1.03B+2.3% | $1B-1.6% | $1.02B-14.5% | $1.19B-8.8% | $1.31B-6.5% | ||
| $34.33M+5.3% | $32.61M+16.9% | $27.89M-1.6% | $28.35M+38.3% | $20.5M-14.2% | ||
| $68.11M-17.9% | $83.01M+21.4% | $68.38M-17.3% | $82.66M-20.6% | $104.13M+5.7% | ||
| $8.94M+1.7% | $8.8M-1.8% | $8.96M+1.5% | $8.83M+11.4% | $7.93M+2.2% | ||
| $3.3M-8.3% | $3.6M-10.0% | $4M-23.1% | $5.2M-3.7% | $5.4M— | ||
| $73.56M-20.7% | $92.82M+23.4% | $75.22M-28.4% | $105M-23.5% | $137.29M+14.7% | ||
| $86.64M-2.7% | $89.05M-2.4% | $91.22M-2.3% | $93.41M+5.9% | $88.17M-2.2% | ||
| $19.42M-10.0% | $21.58M+62.2% | $13.31M+2.1% | $13.03M-12.0% | $14.81M+1.6% | ||
| $212.82M-10.4% | $237.55M+6.4% | $223.36M-8.9% | $245.06M-7.1% | $263.91M+6.2% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| 300M0.0% | 300M0.0% | 300M0.0% | 300M0.0% | 300M+2,142,757% | ||
| $2.14B+8.9% | $1.97B+0.6% | $1.95B+0.6% | $1.94B+0.8% | $1.93B+0.8% | ||
| -$1.32B-10.5% | -$1.2B-3.7% | -$1.15B-16.5% | -$991.71M-12.6% | -$880.75M-15.9% | ||
| -$3.48M-69.3% | -$2.06M-7.6% | -$1.91M+14.0% | -$2.22M-12.5% | -$1.98M-15.0% | ||
| $812.77M+6.2% | $765.28M-3.9% | $796.1M-16.0% | $947.47M-9.2% | $1.04B-9.3% | ||
| $1.03B+2.3% | $1B-1.6% | $1.02B-14.5% | $1.19B-8.8% | $1.31B-6.5% | ||
| $196.28M-14.2% | $228.75M-30.2% | $327.75M-15.5% | $387.65M-25.1% | $517.37M-23.7% | ||
| $60.76M-2.2% | $62.1M-2.3% | $63.56M-2.0% | $64.85M+10.7% | $58.56M-1.9% | ||
| $7.78M-0.9% | $7.85M-0.9% | $7.92M-0.9% | $8M-0.9% | $8.07M-0.6% | ||
| $332.97M+5.8% | $314.58M+3.4% | $304.21M+6.3% | $286.1M+31.2% | $218.14M+14.8% | ||
| $60.76M-2.2% | $62.1M-2.3% | $63.56M-2.0% | $64.85M+10.7% | $58.56M-1.9% | ||
| $24.04M-2.7% | $24.7M+54.6% | $15.98M+21.2% | $13.19M+125% | $5.86M-51.4% | ||
| $103.06M+0.3% | $102.78M+0.1% | $102.69M+0.3% | $102.36M+1.8% | $100.55M+0.6% | ||
| $60.76M-2.2% | $62.1M-2.3% | $63.56M-2.0% | $64.85M+10.7% | $58.56M-1.9% | ||
| $3.39M+1.8% | $3.33M+2.8% | $3.24M+8.3% | $2.99M+44.4% | $2.07M-8.8% | ||
| $33.21M-2.6% | $34.1M-0.2% | $34.18M+1.7% | $33.62M+42.2% | $23.64M-1.7% | ||
| $68.11M-17.9% | $83.01M+21.4% | $68.38M-17.3% | $82.66M-20.6% | $104.13M+5.7% | ||
| $95.58M-2.3% | $97.85M-2.3% | $100.18M-2.0% | $102.23M+6.4% | $96.1M-1.8% | ||
| $17.9M+3.5% | $17.3M-1.1% | $17.5M+1.7% | $17.2M-7.0% | $18.5M+3.4% | ||
| $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| 161.2M+15.6% | 139.5M+0.3% | 139M+0.1% | 138.9M+0.6% | 138.1M+0.8% | ||
| 10M0.0% | 10M0.0% | 10M0.0% | 10M0.0% | 10M0.0% | ||
| 0— | 0— | 0— | 0— | 0— | ||
| 0— | 0— | 0— | 0— | 0— | ||
| $16K+14.3% | $14K0.0% | $14K0.0% | $14K0.0% | $14K0.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| $325K-71.1% | $1.12M-2.0% | $1.15M+31.6% | $871K-24.7% | $1.16M— | ||
| $685K+3,325% | $20K-70.1% | $67K+26.4% | $53K+23.3% | $43K— | ||
| $103.06M+0.3% | $102.78M+0.1% | $102.69M+0.3% | $102.36M+1.8% | $100.55M+0.6% | ||
| $9.04M-68.5% | $28.72M+41.0% | $20.37M— | —— | —— | ||
| $3.39M+1.8% | $3.33M+2.8% | $3.24M+8.3% | $2.99M+44.4% | $2.07M-8.8% | ||
| $37.8M+7.1% | $35.3M+10.2% | $32.03M— | —— | —— | ||
| $685K+3,325% | $20K-70.1% | $67K+26.4% | $53K+23.3% | $43K— | ||
| $325K-71.1% | $1.12M-2.0% | $1.15M+31.6% | $871K-24.7% | $1.16M— | ||
| $809.27M+3.5% | $781.59M-3.6% | $810.73M— | —— | —— | ||
| $35.11M-64.5% | $98.96M+459% | $17.71M— | —— | —— | ||
| $00.0% | $00.0% | $00.0% | $00.0% | $00.0% | ||
| $300M0.0% | $300M0.0% | $300M0.0% | $300M0.0% | $300M0.0% | ||
| $161.23M+15.6% | $139.47M+0.3% | $139.02M+0.1% | $138.89M+0.6% | $138.06M+0.8% | ||
| $161.23M+15.6% | $139.47M+0.3% | $139.02M+0.1% | $138.89M+0.6% | $138.06M+0.8% | ||
| $1.83M+0.2% | $1.83M-13.8% | $2.12M-81.0% | $11.12M-0.5% | $11.18M-3.6% | ||
| $776.58M+13.6% | $683.36M-13.7% | $791.47M-9.5% | $875M-11.5% | $989.09M-8.2% | ||
| $7.11M+41.2% | $5.04M+203% | $1.66M-44.2% | $2.98M-13.6% | $3.45M-10.9% | ||
| $00.0% | $00.0% | $00.0% | $00.0% | $00.0% | ||
| $10M0.0% | $10M0.0% | $10M0.0% | $10M0.0% | $10M0.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $17.9M+3.5% | $17.3M-1.1% | $17.5M+1.7% | $17.2M-7.0% | $18.5M+3.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Vir Biotechnology, Inc.'s total assets?
- Vir Biotechnology, Inc. (VIR) holds $1.0B in total assets, down 21.6% year over year.
- How much debt does Vir Biotechnology, Inc. have?
- Vir Biotechnology, Inc. carries $95.6M in total debt against $812.8M of shareholders' equity, a debt-to-equity ratio of 0.12.
- How much cash does Vir Biotechnology, Inc. have?
- Vir Biotechnology, Inc. holds $283.0M in cash and equivalents.
- Can Vir Biotechnology, Inc. cover its short-term obligations?
- Its current ratio is 7.11 — current assets exceed current liabilities.
- Where does Vir Biotechnology, Inc.'s balance sheet data come from?
- Every line is extracted from Vir Biotechnology, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
